Clinicians Applaud New Law Protecting Patients' Access to Biomarker Testing
Precision medicine legislation paves the way for patients to access life-saving testing and treatmentĀ
The legislation requires health insurance plans to cover biomarker testing for the purposes of diagnosis, treatment, prognosis, management and disease monitoring.
Biomarker Testing Allows for Precise Treatment
Biomarker tests let health care professionals identify the specific cause of a condition down to the cell. With a precise understanding of a patient's condition, health care providers can develop a treatment path tailored to a patient's specific needs. Biomarker tests are often considered part of precision medicine, an individualized treatment approach that leads to optimal health outcomes.
Getting the right treatment swiftly can help patients limit their disease progression and avoid less desirable treatments.
But barriers like coverage and utilization management can block patients and providers from accessing these life-saving tests and their targeted follow-on treatments.
Learn more about the value of precision medicine and biomarker testing in this Q&A document.
STATEMENT FROMĀ BRUCE RUBIN, MD, PRACTICING NEUROLOGIST IN
About the Alliance for Patient Access
The Alliance for Patient Access is a network of policy-minded health care providers who advocate for patient-centered care.
View original content to download multimedia:https://www.prnewswire.com/news-releases/clinicians-applaud-new-law-protecting-patients-access-to-biomarker-testing-302176129.html
SOURCE Alliance for Patient Access
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Bugatti Showcases Steve Dimopoulos' One-of-One Chiron at Pebble Beach Automotive Week
- CPKC and IBEW agree to binding arbitration ending strike
- SuperiorMed Holdings Limited Announces Entering into an Agreement and Plan of Merger with Starry Sea Acquisition Corp
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share